MAY 14, 2019 11:52 AM PDT

EU Weighs Options for Massive Cancer Research Mission

WRITTEN BY: Julia Travers

The European Union (EU) is considering whether and how to launch a moon shot cancer research mission -- a massive commitment and investment in curing cancer. The effort is led by EU Research Commissioner Carlos Moedas, who said in April 2019, “Cancer has evolved and we need new tactics to match it. We need the scale and the critical mass at the EU level, to give it our best shot.” Not surprisingly, how to go about building such an endeavor and where to direct resources are sources of much debate within the union.

Carlos Moedas, credit: UCL Mathematical & Physical Sciences on Flickr, CC 2.0

As more people live longer, cancer is also on the rise. According to the International Agency for Research on Cancer, the number of new incidences of cancer per year will reach more than 22 million by 2030. Cancer is a serious issue in the EU, which holds less than 10 percent of the world’s population but more than 25 percent of cancer cases, according to Science Business.

One of the key theories behind the proposed research mission is increased connectivity between EU governments and the myriad professionals whose work relates to cancer. Moedas is calling for bridges to be built between researchers, various academic disciplines, drug companies and government agencies.

“Focusing on oncologists is no longer enough for cancer treatment. We need oncologists, nutritionists, economists and the patients themselves. We should leverage the European networks we have already on cancer,” he said. An association of seven European cancer centers called Cancer Core Europe wants to be the “engine” of the new mission.

This undertaking would fall within the EU’s “Horizon Europe” research program, which will run from 2021 to 2027. Other goals being considered within this plan include cutting back on plastic pollution and building quantum computers. Horizon Europe has a proposed budget of 94.1 billion euros (~ $105.51 billion), but Christian Ehler, one of the lead authors of the new undertaking, said more money is needed. At this level, he said, “You don’t see missions. At 125 billion euros, you can see missions, at 160 billion euros you can start to fight Alzheimer’s.”

Whether to target specific cancers and, if so, which ones, is also a point of contention.

Map of EU, credit: public domain

 

Source: Science Business

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech and conservation.
You May Also Like
MAR 01, 2019
Cancer
MAR 01, 2019
Enzymes Form a Molecular Switch Vital to Cell Division
Cell division is one of the most fundamental processes in biology. In eukaryotes, there are several phases of the cycle, during which DNA is replicated and...
DEC 11, 2018
Immunology
DEC 11, 2018
Penetrating Brain Tumors
A team of researchers reveals potential targets for glioma tumors....
DEC 19, 2018
Immunology
DEC 19, 2018
Breast Cancer - Immunotherapy's Nemesis
Researchers find that breast cancer can evade immunotherapy...
MAR 19, 2019
Clinical & Molecular DX
MAR 19, 2019
Prevention is Better Than Cure: Early Stage Liver Cancer Detection Using Liquid Biopsy
The scientists emphasized on the importance of HCCscreening technology for liquid biopsies in early stage liver cancer detection and increased survival rate of the patients at high risk....
MAR 31, 2019
Drug Discovery
MAR 31, 2019
Glowing Tumors Reveal How Immunotherapeutics Work
In a study published in the Journal of Clinical Investigation, researchers used positron emission tomography (PET) scans to examine how an immunotherapy dr...
MAY 02, 2019
Cancer
MAY 02, 2019
Cannabis Slows Lung Cancer in Mice
Scientists in Thailand have discovered that cannabinoids can slow the growth of lung cancer in mice. Human trials are planned....
Loading Comments...